{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:21:51Z","timestamp":1774610511008,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The coronavirus disease 19 (COVID-19) pandemic is currently the most acute healthcare challenge in the world. Despite growing knowledge of the nature of Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2), treatment options are still poorly defined. The safety of non-steroidal anti-inflammatory drugs (NSAIDs), specifically ibuprofen, has been openly questioned without any supporting evidence or clarity over dose, duration, or temporality of administration. This has been further conflicted by the initiation of studies to assess the efficacy of ibuprofen in improving outcomes in severe COVID-19 patients. To clarify the scientific reality, a literature search was conducted alongside considerations of the pharmacological properties of ibuprofen in order to construct this narrative review. The literature suggests that double-blind, placebo-controlled study results must be reported and carefully analysed for safety and efficacy in patients with COVID-19 before any recommendations can be made regarding the use of ibuprofen in such patients. Limited studies have suggested: (i) no direct interactions between ibuprofen and SARS-CoV-2 and (ii) there is no evidence to suggest ibuprofen affects the regulation of angiotensin-converting-enzyme 2 (ACE2), the receptor for COVID-19, in human studies. Furthermore, in vitro studies suggest ibuprofen may facilitate cleavage of ACE2 from the membrane, preventing membrane-dependent viral entry into the cell, the clinical significance of which is uncertain. Additionally, in vitro evidence suggests that inhibition of the transcription factor nuclear factor-\u03baB (NF-kB) by ibuprofen may have a role in reducing excess inflammation or cytokine release in COVID-19 patients. Finally, there is no evidence that ibuprofen will aggravate or increase the chance of infection of COVID-19.<\/jats:p>","DOI":"10.1007\/s10787-020-00745-z","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T15:04:00Z","timestamp":1597417440000},"page":"1141-1152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality"],"prefix":"10.1007","volume":"28","author":[{"given":"Lucinda","family":"Smart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-7341","authenticated-orcid":false,"given":"Neil","family":"Fawkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Goggin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Pennick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"Rainsford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Charlesworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"745_CR1","doi-asserted-by":"publisher","first-page":"H1080","DOI":"10.1152\/ajpheart.00215.2020","volume":"318","author":"Z Abassi","year":"2020","unstructured":"Abassi Z, Assady S, Khoury EE, Heyman SN (2020) Letter to the editor: angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications. Am J Physiol Heart Circ Physiol 318:H1080\u2013H1083. https:\/\/doi.org\/10.1152\/ajpheart.00215.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"745_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/adc.2005.071761","volume":"90","author":"AK Akobeng","year":"2005","unstructured":"Akobeng AK (2005) Principles of evidence based medicine. Arch Dis Child 90:837\u2013840. https:\/\/doi.org\/10.1136\/adc.2005.071761","journal-title":"Arch Dis Child"},{"key":"745_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1074248412460124","volume":"18","author":"MS Alghamri","year":"2013","unstructured":"Alghamri MS, Weir NM, Anstadt MP, Elased KM, Gurley SB, Morris M (2013) Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice. J Cardiovasc Pharmacol Ther 18:138\u2013151. https:\/\/doi.org\/10.1177\/1074248412460124","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"745_CR4","doi-asserted-by":"publisher","first-page":"10087","DOI":"10.18632\/aging.103415","volume":"12","author":"R Asselta","year":"2020","unstructured":"Asselta R, Paraboschi EM, Mantovani A, Duga S (2020) ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging 12:10087\u201310098. https:\/\/doi.org\/10.18632\/aging.103415","journal-title":"Aging"},{"key":"745_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/CS20200163","volume":"134","author":"D Batlle","year":"2020","unstructured":"Batlle D, Wysocki J, Satchell K (2020) Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci (Lond) 134:543\u2013545. https:\/\/doi.org\/10.1042\/CS20200163","journal-title":"Clin Sci (Lond)"},{"key":"745_CR6","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1073\/pnas.0809524106","volume":"106","author":"S Belouzard","year":"2009","unstructured":"Belouzard S, Chu VC, Whittaker GR (2009) Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci USA 106:5871\u20135876. https:\/\/doi.org\/10.1073\/pnas.0809524106","journal-title":"Proc Natl Acad Sci USA"},{"key":"745_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13168","author":"J Chen","year":"2020","unstructured":"Chen J et al (2020a) Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell. https:\/\/doi.org\/10.1111\/acel.13168","journal-title":"Aging Cell"},{"key":"745_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa449","author":"X Chen","year":"2020","unstructured":"Chen X et al (2020b) Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa449","journal-title":"Clin Infect Dis"},{"key":"745_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jcf.2015.03.007","volume":"14","author":"JF Chmiel","year":"2015","unstructured":"Chmiel JF et al (2015) Use of ibuprofen to assess inflammatory biomarkers in induced sputum: implications for clinical trials in cystic fibrosis. J Cyst Fibros 14:720\u2013726. https:\/\/doi.org\/10.1016\/j.jcf.2015.03.007","journal-title":"J Cyst Fibros"},{"key":"745_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fped.2020.00206","volume":"8","author":"E Ciaglia","year":"2020","unstructured":"Ciaglia E, Vecchione C, Puca AA (2020) COVID-19 infection and circulating ACE2 levels: protective role in women and children. Front Pediatr 8:206. https:\/\/doi.org\/10.3389\/fped.2020.00206","journal-title":"Front Pediatr"},{"key":"745_CR11","doi-asserted-by":"publisher","first-page":"307315","DOI":"10.1155\/2012\/307315","volume":"2012","author":"NE Clarke","year":"2012","unstructured":"Clarke NE, Turner AJ (2012) Angiotensin-converting enzyme 2: the first decade. Int J Hypertens 2012:307315. https:\/\/doi.org\/10.1155\/2012\/307315","journal-title":"Int J Hypertens"},{"key":"745_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","volume":"417","author":"MA Crackower","year":"2002","unstructured":"Crackower MA et al (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:822\u2013828. https:\/\/doi.org\/10.1038\/nature00786","journal-title":"Nature"},{"key":"745_CR13","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nature05475","volume":"444","author":"U Danilczyk","year":"2006","unstructured":"Danilczyk U et al (2006) Essential role for collectrin in renal amino acid transport. Nature 444:1088\u20131091. https:\/\/doi.org\/10.1038\/nature05475","journal-title":"Nature"},{"key":"745_CR14","doi-asserted-by":"publisher","first-page":"m1086","DOI":"10.1136\/bmj.m1086","volume":"368","author":"M Day","year":"2020","unstructured":"Day M (2020) Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 368:m1086. https:\/\/doi.org\/10.1136\/bmj.m1086","journal-title":"BMJ"},{"key":"745_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007550.pub3","author":"S Derry","year":"2013","unstructured":"Derry S, Best J, Moore RA (2013) Single dose oral dexibuprofen [S(+)-ibuprofen] for acute postoperative pain in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007550.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"745_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/eji.201445222","volume":"45","author":"F Diaz-Gonzalez","year":"2015","unstructured":"Diaz-Gonzalez F, Sanchez-Madrid F (2015) NSAIDs: learning new tricks from old drugs. Eur J Immunol 45:679\u2013686. https:\/\/doi.org\/10.1002\/eji.201445222","journal-title":"Eur J Immunol"},{"key":"745_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M et al (2000) A Novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin i to angiotensin 1\u20139. Circ Res 87:e1\u2013e9. https:\/\/doi.org\/10.1161\/01.RES.87.5.e1","journal-title":"Circ Res"},{"key":"745_CR18","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1210\/en.2004-0443","volume":"145","author":"GC Douglas","year":"2004","unstructured":"Douglas GC, O\u2019Bryan MK, Hedger MP, Lee DK, Yarski MA, Smith AI, Lew RA (2004) The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology 145:4703\u20134711. https:\/\/doi.org\/10.1210\/en.2004-0443","journal-title":"Endocrinology"},{"key":"745_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/HYPERTENSIONAHA.106.070565","volume":"49","author":"TS Elton","year":"2007","unstructured":"Elton TS, Martin MM (2007) Angiotensin II type 1 receptor gene regulation: transcriptional and posttranscriptional mechanisms. Hypertension 49:953\u2013961. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.106.070565","journal-title":"Hypertension"},{"key":"745_CR20","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","volume":"52","author":"S Epelman","year":"2008","unstructured":"Epelman S, Tang WH, Chen SY, Van Lente F, Francis GS, Sen S (2008) Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J Am Coll Cardiol 52:750\u2013754. https:\/\/doi.org\/10.1016\/j.jacc.2008.02.088","journal-title":"J Am Coll Cardiol"},{"key":"745_CR21","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/S2213-2600(20)30159-4","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020a) Antihypertensive drugs and risk of COVID-19?\u2014Authors\u2019 reply. Lancet Respir Med 8:e32\u2013e33. https:\/\/doi.org\/10.1016\/S2213-2600(20)30159-4","journal-title":"Lancet Respir Med"},{"key":"745_CR22","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020b) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8:e21. https:\/\/doi.org\/10.1016\/S2213-2600(20)30116-8","journal-title":"Lancet Respir Med"},{"key":"745_CR23","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.joca.2013.06.026","volume":"21","author":"L Gallelli","year":"2013","unstructured":"Gallelli L et al (2013) The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial. Osteoarthr Cartil 21:1400\u20131408. https:\/\/doi.org\/10.1016\/j.joca.2013.06.026","journal-title":"Osteoarthr Cartil"},{"issue":"368","key":"745_CR24","doi-asserted-by":"publisher","first-page":"m810","DOI":"10.1136\/bmj.m810","volume":"2020","author":"AR Garami","year":"2020","unstructured":"Garami AR (2020) Rapid Response: re: Preventing a covid-19 pandemic\u2014is there a magic bullet to save COVID-19 patients? We can give it a try! BMJ 2020(368):m810. https:\/\/doi.org\/10.1136\/bmj.m810","journal-title":"BMJ"},{"key":"745_CR25","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M et al (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 79:859. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"},{"key":"745_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631\u2013637. https:\/\/doi.org\/10.1002\/path.1570","journal-title":"J Pathol"},{"key":"745_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1161\/HYPERTENSIONAHA.111.184986","volume":"59","author":"LM Hilliard","year":"2012","unstructured":"Hilliard LM, Jones ES, Steckelings UM, Unger T, Widdop RE, Denton KM (2012) Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. Hypertension 59:409\u2013414. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.184986","journal-title":"Hypertension"},{"issue":"271\u2013280","key":"745_CR28","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(271\u2013280):e278. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"745_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"745_CR30","doi-asserted-by":"publisher","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","volume":"289","author":"M Igase","year":"2005","unstructured":"Igase M, Strawn WB, Gallagher PE, Geary RL, Ferrario CM (2005) Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 289:H1013\u2013H1019. https:\/\/doi.org\/10.1152\/ajpheart.00068.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"745_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y et al (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436:112\u2013116. https:\/\/doi.org\/10.1038\/nature03712","journal-title":"Nature"},{"key":"745_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13119","author":"Z Imam","year":"2020","unstructured":"Imam Z et al (2020) Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan. J Intern Med. https:\/\/doi.org\/10.1111\/joim.13119","journal-title":"J Intern Med"},{"key":"745_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01815-18","author":"N Iwata-Yoshikawa","year":"2019","unstructured":"Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N (2019) TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol. https:\/\/doi.org\/10.1128\/JVI.01815-18","journal-title":"J Virol"},{"key":"745_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","volume":"8","author":"JM Jin","year":"2020","unstructured":"Jin JM et al (2020) Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 8:152. https:\/\/doi.org\/10.3389\/fpubh.2020.00152","journal-title":"Front Public Health"},{"key":"745_CR35","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.RES.0000187500.24964.7A","volume":"97","author":"S Keidar","year":"2005","unstructured":"Keidar S et al (2005) Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Res 97:946\u2013953. https:\/\/doi.org\/10.1161\/01.RES.0000187500.24964.7A","journal-title":"Circ Res"},{"key":"745_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/1042517021000021608","volume":"13","author":"T Komatsu","year":"2002","unstructured":"Komatsu T et al (2002) Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2). DNA Seq 13:217\u2013220. https:\/\/doi.org\/10.1080\/1042517021000021608","journal-title":"DNA Seq"},{"key":"745_CR37","doi-asserted-by":"publisher","first-page":"E715","DOI":"10.1073\/pnas.1715035115","volume":"115","author":"DM Kristensen","year":"2018","unstructured":"Kristensen DM et al (2018) Ibuprofen alters human testicular physiology to produce a state of compensated hypogonadism. Proc Natl Acad Sci USA 115:E715\u2013E724. https:\/\/doi.org\/10.1073\/pnas.1715035115","journal-title":"Proc Natl Acad Sci USA"},{"key":"745_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K et al (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11:875\u2013879. https:\/\/doi.org\/10.1038\/nm1267","journal-title":"Nat Med"},{"key":"745_CR39","doi-asserted-by":"publisher","first-page":"30113","DOI":"10.1074\/jbc.M505111200","volume":"280","author":"DW Lambert","year":"2005","unstructured":"Lambert DW et al (2005) Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 280:30113\u201330119. https:\/\/doi.org\/10.1074\/jbc.M505111200","journal-title":"J Biol Chem"},{"key":"745_CR40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1113\/expphysiol.2007.040352","volume":"93","author":"RA Lew","year":"2008","unstructured":"Lew RA, Warner FJ, Hanchapola I, Yarski MA, Ramchand J, Burrell LM, Smith AI (2008) Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp Physiol 93:685\u2013693. https:\/\/doi.org\/10.1113\/expphysiol.2007.040352","journal-title":"Exp Physiol"},{"key":"745_CR41","first-page":"4180","volume":"59","author":"B Lin","year":"1999","unstructured":"Lin B et al (1999) Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res 59:4180\u20134184","journal-title":"Cancer Res"},{"key":"745_CR42","doi-asserted-by":"publisher","first-page":"17021","DOI":"10.1038\/celldisc.2017.21","volume":"3","author":"Q Liu","year":"2017","unstructured":"Liu Q et al (2017) miRNA-200c-3p is crucial in acute respiratory distress syndrome. Cell Discov 3:17021. https:\/\/doi.org\/10.1038\/celldisc.2017.21","journal-title":"Cell Discov"},{"key":"745_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047549","author":"PP Liu","year":"2020","unstructured":"Liu PP, Blet A, Smyth D, Li H (2020a) The science underlying COVID-19: implications for the cardiovascular system. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047549","journal-title":"Circulation"},{"key":"745_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","volume":"63","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020b) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63:364\u2013374. https:\/\/doi.org\/10.1007\/s11427-020-1643-8","journal-title":"Sci China Life Sci"},{"key":"745_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-015-0239-7","volume":"14","author":"H Luo","year":"2015","unstructured":"Luo H et al (2015) Chronic NF-kappaB blockade improves renal angiotensin II type 1 receptor functions and reduces blood pressure in Zucker diabetic rats. Cardiovasc Diabetol 14:76. https:\/\/doi.org\/10.1186\/s12933-015-0239-7","journal-title":"Cardiovasc Diabetol"},{"key":"745_CR46","doi-asserted-by":"publisher","first-page":"30H","DOI":"10.1016\/s0002-9149(03)00432-6","volume":"91","author":"SI McFarlane","year":"2003","unstructured":"McFarlane SI, Kumar A, Sowers JR (2003) Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am J Cardiol 91:30H\u201337H. https:\/\/doi.org\/10.1016\/s0002-9149(03)00432-6","journal-title":"Am J Cardiol"},{"key":"745_CR47","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/ijms17070797","volume":"17","author":"N Mu\u00f1oz-Durango","year":"2016","unstructured":"Mu\u00f1oz-Durango N, Fuentes CA, Castillo AE, Gonz\u00e1lez-G\u00f3mez LM, Vecchiola A, Fardella CE, Kalergis AM (2016) Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension. Int J Mol Sci 17:797. https:\/\/doi.org\/10.3390\/ijms17070797","journal-title":"Int J Mol Sci"},{"key":"745_CR48","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1016\/S2214-109X(20)30136-4","volume":"8","author":"PN Newton","year":"2020","unstructured":"Newton PN et al (2020) COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Health 8:e754\u2013e755. https:\/\/doi.org\/10.1016\/S2214-109X(20)30136-4","journal-title":"Lancet Glob Health"},{"key":"745_CR49","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153","volume":"39","author":"GY Oudit","year":"2009","unstructured":"Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J (2009) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest 39:618\u2013625. https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02153","journal-title":"Eur J Clin Invest"},{"key":"745_CR50","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1139\/cjpp-2013-0488","volume":"92","author":"N Parajuli","year":"2014","unstructured":"Parajuli N, Ramprasath T, Patel VB, Wang W, Putko B, Mori J, Oudit GY (2014) Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases. Can J Physiol Pharmacol 92:558\u2013565. https:\/\/doi.org\/10.1139\/cjpp-2013-0488","journal-title":"Can J Physiol Pharmacol"},{"key":"745_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000375362","volume":"131","author":"W Qiao","year":"2015","unstructured":"Qiao W et al (2015) Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats. Cardiology 131:97\u2013106. https:\/\/doi.org\/10.1159\/000375362","journal-title":"Cardiology"},{"key":"745_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-0496-7","volume-title":"Ibuprofen: pharmacology, therapeutics and side effects.","author":"KD Rainsford","year":"2012","unstructured":"Rainsford KD (2012) Ibuprofen: pharmacology, therapeutics and side effects. Springer, New York"},{"key":"745_CR53","doi-asserted-by":"crossref","DOI":"10.1002\/9781118743614","volume-title":"Ibuprofen: discovery, development and therapeutics","author":"KD Rainsford","year":"2015","unstructured":"Rainsford KD (2015) Ibuprofen: discovery, development and therapeutics. Wiley-Blackwell, Hoboken"},{"key":"745_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fimmu.2015.00361","volume":"6","author":"I Ramos","year":"2015","unstructured":"Ramos I, Fernandez-Sesma A (2015) Modulating the innate immune response to influenza a virus: potential therapeutic use of anti-inflammatory drugs. Front Immunol 6:361. https:\/\/doi.org\/10.3389\/fimmu.2015.00361","journal-title":"Front Immunol"},{"key":"745_CR55","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/01.HYP.0000244543.91937.79","volume":"48","author":"GI Rice","year":"2006","unstructured":"Rice GI, Jones AL, Grant PJ, Carter AM, Turner AJ, Hooper NM (2006) Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension 48:914\u2013920. https:\/\/doi.org\/10.1161\/01.HYP.0000244543.91937.79","journal-title":"Hypertension"},{"key":"745_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.06.003","author":"E Rinott","year":"2020","unstructured":"Rinott E, Kozer E, Shapira Y, Bar-Haim A, Youngster I (2020) Ibuprofen use and clinical outcomes in COVID-19 patients. Clin Microbiol Infect. https:\/\/doi.org\/10.1016\/j.cmi.2020.06.003","journal-title":"Clin Microbiol Infect"},{"key":"745_CR57","doi-asserted-by":"publisher","first-page":"24869","DOI":"10.1039\/c8cp04674c","volume":"20","author":"N Rojas-Valencia","year":"2018","unstructured":"Rojas-Valencia N, Lans I, Manrique-Moreno M, Hadad CZ, Restrepo A (2018) Entropy drives the insertion of ibuprofen into model membranes. Phys Chem 20:24869\u201324876. https:\/\/doi.org\/10.1039\/c8cp04674c","journal-title":"Phys Chem"},{"key":"745_CR58","doi-asserted-by":"publisher","first-page":"e2107","DOI":"10.1002\/rmv.2107","volume":"30","author":"M Rokni","year":"2020","unstructured":"Rokni M, Ghasemi V, Tavakoli Z (2020) Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: comparison with SARS and MERS. Rev Med Virol 30:e2107. https:\/\/doi.org\/10.1002\/rmv.2107","journal-title":"Rev Med Virol"},{"key":"745_CR59","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46:846\u2013848. https:\/\/doi.org\/10.1007\/s00134-020-05991-x","journal-title":"Intensive Care Med"},{"key":"745_CR60","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.bjp.0701652","volume":"123","author":"N Scheuren","year":"1998","unstructured":"Scheuren N, Bang H, Munster T, Brune K, Pahl A (1998) Modulation of transcription factor NF-kappaB by enantiomers of the nonsteroidal drug ibuprofen. Br J Pharmacol 123:645\u2013652. https:\/\/doi.org\/10.1038\/sj.bjp.0701652","journal-title":"Br J Pharmacol"},{"key":"745_CR61","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"AC Simoes e Silva","year":"2013","unstructured":"Simoes e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM (2013) ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol 169:477\u2013492. https:\/\/doi.org\/10.1111\/bph.12159","journal-title":"Br J Pharmacol"},{"key":"745_CR62","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.steroids.2009.07.004","volume":"74","author":"T Sten","year":"2009","unstructured":"Sten T, Finel M, Ask B, Rane A, Ekstr\u00f6m L (2009) Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation. Steroids 74:971\u2013977. https:\/\/doi.org\/10.1016\/j.steroids.2009.07.004","journal-title":"Steroids"},{"key":"745_CR63","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/s1357-2725(02)00271-6","volume":"35","author":"Y Suzuki","year":"2003","unstructured":"Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J (2003) Inflammation and angiotensin II. Int J Biochem Cell Biol 35:881\u2013900. https:\/\/doi.org\/10.1016\/s1357-2725(02)00271-6","journal-title":"Int J Biochem Cell Biol"},{"key":"745_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-020-0311-8","journal-title":"Nat Rev Immunol"},{"key":"745_CR65","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1191\/0961203306lu2306rr","volume":"15","author":"V Teplitsky","year":"2006","unstructured":"Teplitsky V, Shoenfeld Y, Tanay A (2006) The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans. Lupus 15:319\u2013325. https:\/\/doi.org\/10.1191\/0961203306lu2306rr","journal-title":"Lupus"},{"key":"745_CR66","doi-asserted-by":"publisher","first-page":"256294","DOI":"10.1155\/2012\/256294","volume":"2012","author":"C Tikellis","year":"2012","unstructured":"Tikellis C, Thomas MC (2012) Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept 2012:256294. https:\/\/doi.org\/10.1155\/2012\/256294","journal-title":"Int J Pept"},{"key":"745_CR67","doi-asserted-by":"publisher","first-page":"17996","DOI":"10.1074\/jbc.M311191200","volume":"279","author":"P Towler","year":"2004","unstructured":"Towler P et al (2004) ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 279:17996\u201318007. https:\/\/doi.org\/10.1074\/jbc.M311191200","journal-title":"J Biol Chem"},{"issue":"281\u2013292","key":"745_CR68","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181(281\u2013292):e286. https:\/\/doi.org\/10.1016\/j.cell.2020.02.058","journal-title":"Cell"},{"key":"745_CR69","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","volume-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan","author":"C Wu","year":"2020","unstructured":"Wu C et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. JAMA Intern Med, China. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994"},{"key":"745_CR70","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","volume":"78","author":"X Xie","year":"2006","unstructured":"Xie X, Chen J, Wang X, Zhang F, Liu Y (2006) Age- and gender-related difference of ACE2 expression in rat lung. Life Sci 78:2166\u20132171. https:\/\/doi.org\/10.1016\/j.lfs.2005.09.038","journal-title":"Life Sci"},{"key":"745_CR71","doi-asserted-by":"publisher","DOI":"10.1177\/0004563220928361","author":"AE Zemlin","year":"2020","unstructured":"Zemlin AE, Wiese OJ (2020) ANNALS EXPRESS: Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: a closer look at angiotensin-converting enzyme 2 (ACE2). Ann Clin Biochem. https:\/\/doi.org\/10.1177\/0004563220928361","journal-title":"Ann Clin Biochem"},{"key":"745_CR72","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020a) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46:586\u2013590. https:\/\/doi.org\/10.1007\/s00134-020-05985-9","journal-title":"Intensive Care Med"},{"key":"745_CR73","doi-asserted-by":"publisher","first-page":"117583","DOI":"10.1016\/j.lfs.2020.117583","volume":"250","author":"R Zhang","year":"2020","unstructured":"Zhang R et al (2020b) COVID-19: melatonin as a potential adjuvant treatment. Life Sci 250:117583. https:\/\/doi.org\/10.1016\/j.lfs.2020.117583","journal-title":"Life Sci"},{"key":"745_CR74","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/eurheartj\/ehi043","volume":"26","author":"LS Zisman","year":"2005","unstructured":"Zisman LS (2005) ACE and ACE2: a tale of two enzymes. Eur Heart J 26:322\u2013324. https:\/\/doi.org\/10.1093\/eurheartj\/ehi043","journal-title":"Eur Heart J"},{"key":"745_CR75","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"X Zou","year":"2020","unstructured":"Zou X, Chen K, Zou J, Han P, Hao J, Han Z (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14:185\u2013192. https:\/\/doi.org\/10.1007\/s11684-020-0754-0","journal-title":"Front Med"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00745-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-020-00745-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00745-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T23:49:43Z","timestamp":1667778583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-020-00745-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1007\/s10787-020-00745-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"18 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"KR has no conflict of interest to declare. All other authors are employees of Reckitt Benckiser Health Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}